Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

14.99

+0.04 (0.27%)

Oct 2, 2026, 4:00 PM EDT - Market closed

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	804	329	78	7	47	191
Market Cap Growth	371.50%	323.58%	965.79%	-84.63%	-75.15%	-95.47%
Enterprise Value	404	218	-1	-1	52	153
Last Close Price	14.99	18.16	7.43	9.10	1209.61	4895.96

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	13625.65	5581.57	176.29	3.79	2.63	35.37
PB Ratio	1.77	3.97	0.58	1.00	-4.35	8.27
P/TBV Ratio	1.83	4.54	0.63	-	-	22.11

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6845.42	3699.17	-	-	2.87	28.36

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.01	0.01	0.26	-1.98	1.53
Net Debt / Equity Ratio	-0.89	-1.18	-1.00	-0.75	-0.78	-0.83
Net Debt / EBITDA Ratio	4.38	1.35	3.28	0.24	-0.28	0.24
Net Debt / FCF Ratio	5.86	1.90	2.72	0.18	-0.32	0.27
Asset Turnover	0	0	0.01	0.07	0.32	0.09
Inventory Turnover	-	-	-	-	896.21	2444.83
Quick Ratio	18.94	7.60	19.33	1.64	0.68	2.99
Current Ratio	19.31	8.14	19.95	1.82	0.74	3.11
Return on Equity (ROE)	-36.27%	-72.44%	-50.06%	-	-684.77%	-354.08%
Return on Assets (ROA)	-18.50%	-34.12%	-29.75%	-53.91%	-32.95%	-82.82%
Return on Invested Capital (ROIC)	-517.90%	-	-6834.61%	-359.43%	-396.92%	-1501.54%
Return on Capital Employed (ROCE)	-19.50%	-70.40%	-28.40%	-143.20%	-266.10%	-136.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-12.48%	-23.76%	-45.18%	-432.43%	-87.80%	-44.19%
FCF Yield	-8.49%	-15.63%	-63.10%	-422.75%	-56.58%	-37.19%
Buyback Yield / Dilution	-158.89%	-78.82%	-2599.19%	-608.45%	-8.32%	-41.86%

SEC Filings: 10-K · 10-Q